Four IgA antibodies directed against different tumor-associated targets for solid cancer indications (Her2, EGFR, TA-MUC1, TF) were biofunctional in ADCC assays using granulocytes as effector cells and corresponding target cell lines. The gene discussed is ERBB2; the disease is neoplasm.